22 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Gainers

• Nabriva Therapeutics, Inc. NBRV stock moved upwards by 24.9% to $2.76 during Tuesday's pre-market session. The market value of their outstanding shares is at $176.8 million.
• Tonix Pharmaceuticals, Inc. TNXP shares moved upwards by 22.8% to $0.58. The market cap seems to be at $19.6 million.
• VIVUS, Inc. VVUS shares moved upwards by 22.6% to $4.17. The market cap seems to be at $23.7 million.
• Soliton, Inc. SOLY shares increased by 13.0% to $12.50.
• Bellicum Pharmaceuticals, Inc. BLCM stock increased by 9.7% to $1.02.
• Restoration Robotics, Inc. HAIR stock surged 8.0% to $0.74. The market cap stands at $22.8 million.
• Moleculin Biotech, Inc. MBRX stock increased by 7.0% to $1.23.
• Medtronic, Inc. MDT stock surged 4.4% to $108.75. The most recent rating by Deutsche Bank, on August 19, is at Buy, with a price target of $111.00.
• Outlook Therapeutics, Inc. OTLK stock moved upwards by 4.1% to $2.04.
• Canopy Growth, Inc. CGC stock moved upwards by 4.0% to $27.80. The most recent rating by Ladenburg Thalmann, on July 17, is at Buy, with a price target of $50.00.
• Clovis Oncology, Inc. CLVS shares increased by 3.4% to $6.15. The most recent rating by Bank of America, on August 13, is at Neutral, with a price target of $7.00.
• Acasti Pharma, Inc. ACST shares increased by 2.2% to $1.83. The most recent rating by Oppenheimer, on July 18, is at Outperform, with a price target of $7.00.

Losers

• Synlogic, Inc. SYBX shares plummeted 20.9% to $3.82 during Tuesday's pre-market session.
• NuCana, Inc. NCNA stock plummeted 20.5% to $5.82. The market value of their outstanding shares is at $290.1 million. The most recent rating by H.C. Wainwright, on August 19, is at Buy, with a price target of $20.00.
• Sarepta Therapeutics, Inc. SRPT shares fell 16.6% to $100.30. The most recent rating by Janney Capital, on August 20, is at Buy, with a price target of $175.00.
• Gemphire Therapeutics, Inc. GEMP stock fell 10.8% to $0.50. The market cap stands at $101.9 million.
• Miragen Therapeutics, Inc. MGEN shares plummeted 8.1% to $1.25. The most recent rating by H.C. Wainwright, on August 19, is at Buy, with a price target of $3.00.
• TrovaGene, Inc. TROV shares decreased by 8.0% to $2.76.
• Plus Therapeutics, Inc. PSTV shares decreased by 6.9% to $8.38. The market value of their outstanding shares is at $226.6 million.
• Hepion Pharmaceuticals, Inc. HEPA stock fell 6.0% to $2.35.
• Elanco Animal Health, Inc. ELAN stock declined 6.0% to $28.00. The market cap stands at $11.5 billion. The most recent rating by UBS, on August 15, is at Neutral, with a price target of $30.00.
• SELLAS Life Sciences, Inc. SLS shares decreased by 3.2% to $0.15. The market value of their outstanding shares is at $27.0 million.